The high mobility group box: The ultimate utility player of a cell

Trends in Biochemical Sciences

Volumn 37, Issue 12, 2012, Pages 553-562

  Malarkey, Christopher S ^a   Churchill, Mair E A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

DNA recognition; High mobility group (HMG) box protein; Post translational modifications

Indexed keywords

CELL RECEPTOR; DNA DIRECTED DNA POLYMERASE ALPHA; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; OCTAMER TRANSCRIPTION FACTOR; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR SOX;

CELLULAR DISTRIBUTION; CHROMATIN; DNA SEQUENCE; DROSOPHILA MELANOGASTER; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HIGH MOBILITY GROUP PROTEINS; HUMANS; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 84870033804     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.09.003     Document Type: Review

References (90)

1. Goodwin G.H., et al. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 1973, 38:14-19.
2. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 2001, 26:152-153.
3. Reeves R. Nuclear functions of the HMG proteins. Biochim. Biophys. Acta 2010, 1799:3-14.
4. Sgarra R., et al. HMGA molecular network: from transcriptional regulation to chromatin remodeling. Biochim. Biophys. Acta 2010, 1799:37-47.
5. Gerlitz G. HMGNs, DNA repair and cancer. Biochim. Biophys. Acta 2010, 1799:80-85.
6. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26:167-174.
7. Asin-Cayuela J., Gustafsson C.M. Mitochondrial transcription and its regulation in mammalian cells. Trends Biochem. Sci. 2007, 32:111-117.
8. Bonawitz N.D., et al. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol. Cell 2006, 24:813-825.
9. Bianchi M.E., Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 2005, 15:496-506.
10. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta 2010, 1799:101-113.
11. Thomas J.O. HMG1 and 2: architectural DNA-binding proteins. Biochem. Soc. Trans. 2001, 29:395-401.
12. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
13. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 2011, 29:139-162.
14. Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol. Rev. 2011, 240:92-104.
15. Kang R., et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18:571-580.
16. Soullier S., et al. Diversification pattern of the HMG and SOX family members during evolution. J. Mol. Evol. 1999, 48:517-527.
17. Landsman D., Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays 1993, 15:539-546.
18. Murphy F.V., Churchill M.E. Nonsequence-specific DNA recognition: a structural perspective. Structure 2000, 8:R83-R89.
19. Churchill M.E., et al. Structural analysis of HMGD-DNA complexes reveals influence of intercalation on sequence selectivity and DNA bending. J. Mol. Biol. 2010, 403:88-102.
20. Masse J.E., et al. The S. cerevisiae architectural HMGB protein NHP6A complexed with DNA: DNA and protein conformational changes upon binding. J. Mol. Biol. 2002, 323:263-284.
21. Leung W.K., et al. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J. Biol. Chem. 2000, 275:15728-15732.
22. Park S., Lippard S.J. Binding interaction of HMGB4 with cisplatin-modified DNA. Biochemistry 2012, 51:6728-6737.
23. Fisher R.P., Clayton D.A. Purification and characterization of human mitochondrial transcription factor 1. Mol. Cell. Biol. 1988, 8:3496-3509.
24. Alam T.I., et al. Human mitochondrial DNA is packaged with TFAM. Nucleic Acids Res. 2003, 31:1640-1645.
25. Privalov P.L., et al. The cost of DNA bending. Trends Biochem. Sci. 2009, 34:464-470.
26. Weir H.M., et al. Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 1993, 12:1311-1319.
27. Churchill M.E., et al. Interactions of high mobility group box proteins with DNA and chromatin. Methods Enzymol. 1999, 304:99-133.
28. Malarkey C.S., et al. Transcriptional activation by mitochondrial transcription factor A involves preferential distortion of promoter DNA. Nucleic Acids Res. 2012, 40:614-624.
29. Stott K., et al. Structure of a complex of tandem HMG boxes and DNA. J. Mol. Biol. 2006, 360:90-104.
30. Rubio-Cosials A., et al. Human mitochondrial transcription factor A induces a U-turn structure in the light strand promoter. Nat. Struct. Mol. Biol. 2011, 18:1281-1289.
31. Ngo H.B., et al. The mitochondrial transcription and packaging factor Tfam imposes a U-turn on mitochondrial DNA. Nat. Struct. Mol. Biol. 2011, 18:1290-1296.
32. Werner M.H., et al. Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 1995, 81:705-714.
33. Murphy F.V., et al. The structure of a chromosomal high mobility group protein-DNA complex reveals sequence-neutral mechanisms important for non-sequence-specific DNA recognition. EMBO J. 1999, 18:6610-6618.
34. Ohndorf U.M., et al. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 1999, 399:708-712.
35. Wong T.S., et al. Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53. Nucleic Acids Res. 2009, 37:6765-6783.
36. Gangelhoff T.A., et al. Structural analysis and DNA binding of the HMG domains of the human mitochondrial transcription factor A. Nucleic Acids Res. 2009, 37:3153-3164.
37. Muller S., et al. Thermodynamics of HMGB1 interaction with duplex DNA. Biochemistry 2001, 40:10254-10261.
38. Rohs R., et al. Origins of specificity in protein-DNA recognition. Annu. Rev. Biochem. 2010, 79:233-269.
39. Zhao Y., Stormo G.D. Quantitative analysis demonstrates most transcription factors require only simple models of specificity. Nat. Biotechnol. 2011, 29:480-483.
40. Badis G., et al. Diversity and complexity in DNA recognition by transcription factors. Science 2009, 324:1720-1723.
41. Jauch R., et al. Crystal structure of the Sox4 HMG/DNA complex suggests a mechanism for the positional interdependence in DNA recognition. Biochem. J. 2012, 443:39-47.
42. Palasingam P., et al. The structure of Sox17 bound to DNA reveals a conserved bending topology but selective protein interaction platforms. J. Mol. Biol. 2009, 388:619-630.
43. Jauch R., et al. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA. Stem Cells 2011, 29:940-951.
44. Kaufman B.A., et al. The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol. Biol. Cell 2007, 18:3225-3236.
45. Litonin D., et al. Human mitochondrial transcription revisited: only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro. J. Biol. Chem. 2010, 285:18129-18133.
46. Dairaghi D.J., et al. Addition of a 29 residue carboxyl-terminal tail converts a simple HMG box-containing protein into a transcriptional activator. J. Mol. Biol. 1995, 249:11-28.
47. Farge G., et al. Protein sliding and DNA denaturation are essential for DNA organization by human mitochondrial transcription factor A. Nat. Commun. 2012, 3:1013.
48. Kondoh H., Kamachi Y. SOX-partner code for cell specification: regulatory target selection and underlying molecular mechanisms. Int. J. Biochem. Cell Biol. 2010, 42:391-399.
49. Ambrosetti D.C., et al. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 1997, 17:6321-6329.
50. Grosschedl R., et al. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 1994, 10:94-100.
51. Remenyi A., et al. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 2003, 17:2048-2059.
52. Williams D.C., et al. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 2004, 279:1449-1457.
53. Roemer S.C., et al. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res. 2008, 36:3655-3666.
54. Stillman D.J. Nhp6: a small but powerful effector of chromatin structure in Saccharomyces cerevisiae. Biochim. Biophys. Acta 2010, 1799:175-180.
55. Langst G., Becker P.B. Nucleosome remodeling: one mechanism, many phenomena?. Biochim. Biophys. Acta 2004, 1677:58-63.
56. Hargreaves D.C., Crabtree G.R. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 2011, 21:396-420.
57. Lai D., et al. Induction of TLR4-target genes entails calcium/calmodulin-dependent regulation of chromatin remodeling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1169-1174.
58. Xin H., et al. yFACT induces global accessibility of nucleosomal DNA without H2A-H2B displacement. Mol. Cell 2009, 35:365-376.
59. Winkler D.D., Luger K. The histone chaperone FACT: structural insights and mechanisms for nucleosome reorganization. J. Biol. Chem. 2011, 286:18369-18374.
60. Tsunaka Y., et al. Phosphorylated intrinsically disordered region of FACT masks its nucleosomal DNA binding elements. J. Biol. Chem. 2009, 284:24610-24621.
61. Ugrinova I., et al. In vivo acetylation of HMG1 protein enhances its binding affinity to distorted DNA structures. Biochemistry 2001, 40:14655-14660.
62. Elenkov I., et al. The DNA binding and bending activities of truncated tail-less HMGB1 protein are differentially affected by Lys-2 and Lys-81 residues and their acetylation. Int. J. Biol. Sci. 2011, 7:691-699.
63. Ugrinova I., et al. Cyclin-dependent kinase 5 phosphorylates mammalian HMGB1 protein only if acetylated. J. Biochem. 2011, 149:563-568.
64. Ito I., et al. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 2007, 282:16336-16344.
65. Bonaldi T., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22:5551-5560.
66. Baltus G.A., et al. Acetylation of sox2 induces its nuclear export in embryonic stem cells. Stem Cells 2009, 27:2175-2184.
67. Hoppe G., et al. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp. Cell Res. 2006, 312:3526-3538.
68. Sahu D., et al. Redox properties of the A-domain of the HMGB1 protein. FEBS Lett. 2008, 582:3973-3978.
69. Park S., Lippard S.J. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Biochemistry 2011, 50:2567-2574.
70. Dow L.K., et al. Oxidation of a critical methionine modulates DNA binding of the Drosophila melanogaster high mobility group protein, HMG-D. FEBS Lett. 1997, 414:514-520.
71. Tang D., et al. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 2011, 14:1315-1335.
72. Evankovich J., et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J. Biol. Chem. 2010, 285:39888-39897.
73. Tang D., et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukoc. Biol. 2007, 81:741-747.
74. Rovere-Querini P., et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004, 5:825-830.
75. Scaffidi P., et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
76. Tang D., et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310.
77. Park J.S., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
78. Yang H., et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11942-11947.
79. Julian M.W., et al. Mitochondrial transcription factor a serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J. Immunol. 2012, 189:433-443.
80. Koopman P., et al. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 1990, 348:450-452.
81. Lefebvre V., et al. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell Biol. 2007, 39:2195-2214.
82. Russell J., Zomerdijk J.C. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem. Sci. 2005, 30:87-96.
83. Arce L., et al. Diversity of LEF/TCF action in development and disease. Oncogene 2006, 25:7492-7504.
84. Sim H., et al. Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol. Metab. 2008, 19:213-222.
85. Yuan H., et al. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995, 9:2635-2645.
86. Sinner D., et al. Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 2007, 27:7802-7815.
87. Colland F., et al. Functional proteomics mapping of a human signaling pathway. Genome Res. 2004, 14:1324-1332.
88. Hyndman B.D., et al. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300. Biochim. Biophys. Acta 2012, 1819:446-453.
89. Hornbeck P.V., et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012, 40:D261-D270.
90. Luscombe N.M., et al. NUCPLOT: a program to generate schematic diagrams of protein-nucleic acid interactions. Nucleic Acids Res. 1997, 25:4940-4945.